|
|
||||
|
Platelet glycoprotein IIb/IIIa should be blocked before stenting
Pre-treatment with eptifibatide, a platelet glycoprotein IIb/IIIa inhibitor, reduces the risk of complications after coronary stenting.
Email: Tudor Toma - ttoma@mail.dntis.ro News from The Scientist 2000, 1(1):20001215-01
|
||||
|
|
||||
|
Eptifibatide, a platelet glycoprotein IIb/IIIa inhibitor substantially reduces ischemic complications in coronary stent interventions and could become a routine pre-treatment in stent coronary implantation, concludes a study published in 16 December Lancet (Lancet 2000 356:2037).
|
|
|||||||||
|
|||||||||
|